Equivalence of basal insulin glargine vs prandial insulin lispro for glucose control in type 2 diabetes patients on oral agents - Results of the APOLLO study

被引：0
|
作者：
Bretzel, Reinhard G.
Linn, Thomas
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A76 / A76
页数：1
相关论文
共 50 条
  • [41] Durability of glycemic control with insulin lispro mix 75/25 versus insulin glargine for older patients with type 2 diabetes
    Lois Jovanovič
    Anne L. Peters
    Honghua H. Jiang
    Dana S. Hardin
    Aging Clinical and Experimental Research, 2014, 26 : 115 - 121
  • [42] Reduced risk of hypoglycaemia with insulin degludec vs insulin glargine in patients with Type 2 diabetes requiring high dose basal insulin
    Gough, S.
    Rodbard, H.
    Handelsman, Y.
    Dykiel, P.
    Lassota, N.
    Lane, W.
    DIABETIC MEDICINE, 2013, 30 : 55 - 55
  • [43] Starting an insulin regimen with insulin lispro mix 25 versus glargine insulin for type 2 diabetes
    Fernandez Lando, Laura
    Massari, Fabio
    Oviedo, Alejandra
    Jiang, Honghua
    MEDICINA-BUENOS AIRES, 2012, 72 (03) : 235 - 242
  • [44] Ultra Rapid Lispro (URLi) accelerates insulin lispro absorption and insulin action vs lispro in patients with type 2 diabetes
    Leohr, J.
    Dellva, M.
    Coutant, D.
    LaBell, E.
    Reddy, S.
    Bowerman, S.
    Heise, T.
    Andersen, G.
    Zijlstra, E.
    Hermanski, L.
    Nosek, L.
    Linnebjerg, H.
    DIABETOLOGIA, 2019, 62 : S381 - S381
  • [45] Incidence of severe nocturnal hypoglycemia in patients with type 1 diabetes treated with insulin lispro or regular human insulin in addition to basal insulin glargine
    Brunetti, P.
    Muggeo, M.
    Cattin, L.
    Arcangeli, A.
    Pozzilli, P.
    Provenzano, V.
    Francesconi, A.
    Calatola, P.
    Santeusanio, F.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2010, 20 (07) : 519 - 526
  • [46] Initiation of Prandial Insulin Therapy with AIR Inhaled Insulin or Insulin Lispro in Patients with Type 2 Diabetes: A Randomized Noninferiority Trial
    Gross, Jorge L.
    Nakano, Masako
    Colon-Vega, Gildred
    Ortiz-Carasquillo, Ramon
    Ferguson, Jeffrey A.
    Althouse, Sandra
    Tobian, Janet A.
    Berclaz, Pierre-Yves
    Milicevic, Zvonko
    DIABETES TECHNOLOGY & THERAPEUTICS, 2009, 11 : S27 - S34
  • [47] A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents
    Ross, SA
    Zinman, B
    Campos, RV
    Strack, T
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 2001, 24 (06): : 292 - 298
  • [48] Randomised open-label trial of insulin lispro protamin suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients
    Giugliano, D.
    Cleall, S.
    Pontiroli, A. E.
    Koivisto, V.
    DIABETOLOGIA, 2011, 54 : S421 - S422
  • [49] Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes mellitus requiring insulin intensification-a randomized phase IV trial: Indian subpopulation analyses
    Prasanna Kumar, K. M.
    Shah, Sanjiv
    Shah, Parag
    Cleall, Simon
    Chen, Steve
    Uppal, Shweta
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2017, 37 (02) : 116 - 123
  • [50] Improvement of blood glucose control with decrease in basal insulin needs and of nocturnal hypoglycemic episodes with insulin glargine vs. NPH in type 1 diabetes patients
    Ramiro, AD
    Thomas, N
    DIABETES, 2004, 53 : A480 - A480
12345